Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO Rep. 2017 01; 18(1):150-168.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Biomarkers
Cell Line, Tumor
Cell Survival
Disease Models, Animal
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Glioma
Humans
JNK Mitogen-Activated Protein Kinases
Mice
Models, Biological
Neoplastic Stem Cells
NF-kappa B
Proteasome Endopeptidase Complex
Proteasome Inhibitors
Signal Transduction
Tumor Cells, Cultured
Ubiquitination
Xenograft Model Antitumor Assays
authors with profiles
Deric Park